These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24406898)

  • 1. Early liraglutide treatment is better in glucose control, β-cell function improvement and mass preservation in db/db mice.
    Shao Y; Yuan G; Feng Y; Zhang J; Guo X
    Peptides; 2014 Feb; 52():134-42. PubMed ID: 24406898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel GLP-1-gastrin dual agonist, ZP3022, increases β-cell mass and prevents diabetes in db/db mice.
    Fosgerau K; Jessen L; Lind Tolborg J; Østerlund T; Schæffer Larsen K; Rolsted K; Brorson M; Jelsing J; Skovlund Ryge Neerup T
    Diabetes Obes Metab; 2013 Jan; 15(1):62-71. PubMed ID: 22862961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
    Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
    Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL; Huang Q; Cao X; Drucker DJ
    Gastroenterology; 2008 Apr; 134(4):1137-47. PubMed ID: 18313669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel GLP-1-gastrin dual agonist ZP3022 improves glucose homeostasis and increases β-cell mass without affecting islet number in db/db mice.
    Dalbøge LS; Almholt DL; Neerup TS; Vrang N; Jelsing J; Fosgerau K
    J Pharmacol Exp Ther; 2014 Aug; 350(2):353-60. PubMed ID: 24902584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide, a human glucagon-like peptide-1 analogue, stimulates AKT-dependent survival signalling and inhibits pancreatic β-cell apoptosis.
    Kapodistria K; Tsilibary EP; Kotsopoulou E; Moustardas P; Kitsiou P
    J Cell Mol Med; 2018 Jun; 22(6):2970-2980. PubMed ID: 29524296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.
    Wang B; Zhong J; Lin H; Zhao Z; Yan Z; He H; Ni Y; Liu D; Zhu Z
    Diabetes Obes Metab; 2013 Aug; 15(8):737-49. PubMed ID: 23433305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liraglutide ameliorates glycometabolism and insulin resistance through the upregulation of GLUT4 in diabetic KKAy mice.
    Chen LN; Lyu J; Yang XF; Ji WJ; Yuan BX; Chen MX; Ma X; Wang B
    Int J Mol Med; 2013 Oct; 32(4):892-900. PubMed ID: 23877319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liraglutide prevents fast weight gain and β-cell dysfunction in male catch-up growth rats.
    Zheng J; Chen T; Zhu Y; Li HQ; Deng XL; Wang QH; Zhang JY; Chen LL
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1165-76. PubMed ID: 25710926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protective effects of glucagon-like peptide-1 on beta-cells: preclinical and clinical data].
    Consoli A; Di Biagio R
    G Ital Cardiol (Rome); 2011 Dec; 12(12 Suppl 2):5-9. PubMed ID: 22158421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liraglutide protects pancreatic beta cells during an early intervention in Gato-Kakizaki rats.
    Luo X; Pan L; Nie A; Wang Q; Gu Y; Li F; Zhang H; Li W; Li X
    J Diabetes; 2013 Dec; 5(4):421-8. PubMed ID: 23590680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes.
    Moffett RC; Patterson S; Irwin N; Flatt PR
    Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Study of Liraglutide and Insulin Glargine on Glycemic Control and Pancreatic β-Cell Function in db/db Mice.
    Li Y; Zheng J; Shen Y; Li W; Liu M; Wang J; Zhu S; Wu M
    Med Sci Monit; 2018 May; 24():3293-3300. PubMed ID: 29777582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.
    Vergès B; Bonnard C; Renard E
    Diabetes Metab; 2011 Dec; 37(6):477-88. PubMed ID: 21871831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intervention with liraglutide improves glucose tolerance without affecting islet microcirculation in young Goto-Kakizaki rats.
    Wu L; Olverling A; Fransson L; Ortsäter H; Kappe C; Gao X; Sjöholm A
    Regul Pept; 2012 Aug; 177(1-3):92-6. PubMed ID: 22587909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BPI-3016, a novel long-acting hGLP-1 analogue for the treatment of Type 2 diabetes mellitus.
    Ding L; Lu S; Wang Y; Chen H; Long W; Ma C; He E; Yan D; Tan F
    Pharmacol Res; 2017 Aug; 122():130-139. PubMed ID: 28619366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The protection of islet β-cells in db/db mice by combination pioglitazone and glucagon like peptide-1 treatment].
    Song LL; Xiao JZ; Yang WY; Zhang M; Liu BB; Pan L
    Zhonghua Nei Ke Za Zhi; 2011 Sep; 50(9):781-4. PubMed ID: 22176969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of pioglitazone and/or liraglutide on pancreatic β-cells in db/db mice: Comparison of their effects between in an early and advanced stage of diabetes.
    Kimura T; Kaneto H; Shimoda M; Hirukawa H; Okauchi S; Kohara K; Hamamoto S; Tawaramoto K; Hashiramoto M; Kaku K
    Mol Cell Endocrinol; 2015 Jan; 400():78-89. PubMed ID: 25463759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.